Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions
Authors
Keywords
-
Journal
PHARMACEUTICAL RESEARCH
Volume 29, Issue 10, Pages 2860-2873
Publisher
Springer Nature
Online
2012-05-25
DOI
10.1007/s11095-012-0792-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Physiologically Based Pharmacokinetic Modeling in Regulatory Review
- (2012) S-M Huang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation
- (2012) Ping Zhao et al. JOURNAL OF CLINICAL PHARMACOLOGY
- pH-Dependent Solubility and Permeability Criteria for Provisional Biopharmaceutics Classification (BCS and BDDCS) in Early Drug Discovery
- (2012) Manthena V. Varma et al. MOLECULAR PHARMACEUTICS
- Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
- (2011) Malcolm Rowland et al. Annual Review of Pharmacology and Toxicology
- Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly
- (2011) Hironobu Akao et al. ATHEROSCLEROSIS
- Mechanism-Based Inactivation of CYP2C8 by Gemfibrozil Occurs Rapidly in Humans
- (2011) J Honkalammi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Role of Organic Anion-Transporting Polypeptides for Cellular Mesalazine (5-Aminosalicylic Acid) Uptake
- (2011) J. Konig et al. DRUG METABOLISM AND DISPOSITION
- Prediction of the Overall Renal Tubular Secretion and Hepatic Clearance of Anionic Drugs and a Renal Drug-Drug Interaction Involving Organic Anion Transporter 3 in Humans by In Vitro Uptake Experiments
- (2011) T. Watanabe et al. DRUG METABOLISM AND DISPOSITION
- Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3
- (2011) Tom De Bruyn et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- pH-Sensitive Interaction of HMG-CoA Reductase Inhibitors (Statins) with Organic Anion Transporting Polypeptide 2B1
- (2011) Manthena V. Varma et al. MOLECULAR PHARMACEUTICS
- In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions
- (2011) Maria Karlgren et al. PHARMACEUTICAL RESEARCH
- The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance
- (2011) Katherine S. Fenner et al. XENOBIOTICA
- Cyclosporine A, but Not Tacrolimus, Shows Relevant Inhibition of Organic Anion-Transporting Protein 1B1-Mediated Transport of Atorvastatin
- (2010) R. Amundsen et al. DRUG METABOLISM AND DISPOSITION
- Physicochemical Space for Optimum Oral Bioavailability: Contribution of Human Intestinal Absorption and First-Pass Elimination
- (2010) Manthena V. S. Varma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Improved Extrapolation of Hepatobiliary Clearance fromin VitroSandwich Cultured Rat Hepatocytes through Absolute Quantification of Hepatobiliary Transporters
- (2010) Na Li et al. MOLECULAR PHARMACEUTICS
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Use of clearance concepts and modeling techniques in the prediction of metabolic drug–drug interactions
- (2010) Kiyomi Ito et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1
- (2010) P. Annaert et al. XENOBIOTICA
- Modelling and PBPK Simulation in Drug Discovery
- (2009) Hannah M. Jones et al. AAPS Journal
- Impact of OATP transporters on pharmacokinetics
- (2009) A Kalliokoski et al. BRITISH JOURNAL OF PHARMACOLOGY
- Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins
- (2009) Michael J. Knauer et al. CIRCULATION RESEARCH
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects
- (2009) Sheng Deng et al. CLINICAL THERAPEUTICS
- The Simcyp®Population-based ADME Simulator
- (2009) Masoud Jamei et al. Expert Opinion on Drug Metabolism & Toxicology
- Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs
- (2009) Ichiro Ieiri et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and Pravastatin
- (2008) Pertti J Neuvonen et al. CLINICAL PHARMACOKINETICS
- The Effect of Gemfibrozil on Repaglinide Pharmacokinetics Persists for at Least 12 h After the Dose: Evidence for Mechanism-based Inhibition of CYP2C8 In Vivo
- (2008) A Tornio et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
- (2008) T. Watanabe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The Quantitative Prediction of CYP-mediated Drug Interaction by Physiologically Based Pharmacokinetic Modeling
- (2008) Motohiro Kato et al. PHARMACEUTICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now